{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T15:29:15Z","timestamp":1782833355451,"version":"3.54.5"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ccm.2018.02.001","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T14:20:37Z","timestamp":1526566837000},"page":"401-410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Metabolic Myopathies and the Respiratory System"],"prefix":"10.1016","volume":"39","author":[{"given":"Patrick","family":"Koo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigme M.","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ccm.2018.02.001_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archneur.55.1.17","article-title":"Mitochondrial myopathies: genetic mechanisms","volume":"55","author":"Rose","year":"1998","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.ccm.2018.02.001_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/07853890.2011.605389","article-title":"Diagnosis and treatment of mitochondrial myopathies","volume":"45","author":"Pfeffer","year":"2013","journal-title":"Ann Med"},{"issue":"18","key":"10.1016\/j.ccm.2018.02.001_bib3","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.3748\/wjg.v13.i18.2541","article-title":"Glycogen storage diseases: new perspectives","volume":"13","author":"Ozen","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.ccm.2018.02.001_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/01913123.2011.601404","article-title":"Glycogen storage diseases: a brief review and update on clinical features, genetic abnormalities, pathologic features, and treatment","volume":"35","author":"Hicks","year":"2011","journal-title":"Ultrastruct Pathol"},{"issue":"4","key":"10.1016\/j.ccm.2018.02.001_bib5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.rmed.2008.12.009","article-title":"Pompe disease: a neuromuscular disease with respiratory muscle involvement","volume":"103","author":"Mellies","year":"2009","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.ccm.2018.02.001_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11910-007-0024-4","article-title":"Acid alpha-glucosidase deficiency (Pompe disease)","volume":"7","author":"Fukuda","year":"2007","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"23 Suppl 2","key":"10.1016\/j.ccm.2018.02.001_bib7","first-page":"S4","article-title":"Diagnosis of glycogenosis type II","volume":"71","author":"Bembi","year":"2008","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.ccm.2018.02.001_bib8","first-page":"875","article-title":"The natural course of non-classic Pompe\u2019s disease; a review of 225 published cases","volume":"252","author":"Winkel","year":"2005","journal-title":"J\u00a0Neurol"},{"issue":"1","key":"10.1016\/j.ccm.2018.02.001_bib9","first-page":"13","article-title":"Myopathy due to a defect in muscle glycogen breakdown","volume":"10","author":"McArdle","year":"1951","journal-title":"Clin Sci"},{"issue":"11","key":"10.1016\/j.ccm.2018.02.001_bib10","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/jnnp.2009.195040","article-title":"McArdle disease: a clinical review","volume":"81","author":"Quinlivan","year":"2010","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.ccm.2018.02.001_bib11","first-page":"157","article-title":"McArdle disease and exercise physiology","volume":"3","author":"Kitaoka","year":"2014","journal-title":"Biology (Basel)"},{"issue":"12","key":"10.1016\/j.ccm.2018.02.001_bib12","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1212\/WNL.56.12.1733","article-title":"A\u00a0non-ischemic forearm exercise test for the screening of patients with exercise intolerance","volume":"56","author":"Hogrel","year":"2001","journal-title":"Neurolog"},{"issue":"2","key":"10.1016\/j.ccm.2018.02.001_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ana.10263","article-title":"A\u00a0nonischemic forearm exercise test for McArdle disease","volume":"52","author":"Kazemi-Esfarjani","year":"2002","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.ccm.2018.02.001_bib14","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1152\/jappl.1992.72.5.1773","article-title":"Effect of deficient muscular glycogenolysis on extramuscular fuel production in exercise","volume":"72","author":"Vissing","year":"1992","journal-title":"J\u00a0Appl Physiol (1985)"},{"issue":"4","key":"10.1016\/j.ccm.2018.02.001_bib15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/mus.20947","article-title":"Increased PFK activity and GLUT4 protein content in McArdle\u2019s disease","volume":"37","author":"Robertshaw","year":"2008","journal-title":"Muscle Nerve"},{"issue":"5\u20136","key":"10.1016\/j.ccm.2018.02.001_bib16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.mam.2004.06.004","article-title":"Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects","volume":"25","author":"Bonnefont","year":"2004","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.ccm.2018.02.001_bib17","first-page":"351","article-title":"State of the art in muscle lipid diseases","volume":"29","author":"Liang","year":"2010","journal-title":"Acta Myol"},{"issue":"4115","key":"10.1016\/j.ccm.2018.02.001_bib18","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.182.4115.929","article-title":"Muscle carnitine palmitoyltransferase deficiency and myoglobinuria","volume":"182","author":"DiMauro","year":"1973","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ccm.2018.02.001_bib19","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1172\/JCI111265","article-title":"Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle","volume":"73","author":"Sabina","year":"1984","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"10.1016\/j.ccm.2018.02.001_bib20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.410270214","article-title":"Metabolic causes of myoglobinuria","volume":"27","author":"Tonin","year":"1990","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.ccm.2018.02.001_bib21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1164\/ajrccm.164.3.2005110","article-title":"Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy","volume":"164","author":"Flaherty","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2018.02.001_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ana.21217","article-title":"Prevalence of mitochondrial DNA disease in adults","volume":"63","author":"Schaefer","year":"2008","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.ccm.2018.02.001_bib23","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1378\/chest.101.3.824","article-title":"Respiratory failure revealing mitochondrial myopathy in adults","volume":"101","author":"Cros","year":"1992","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ccm.2018.02.001_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/1531-8249(199901)45:1<127::AID-ART20>3.0.CO;2-Y","article-title":"A\u00a0nonsense mutation (G15059A) in the cytochrome b gene in a patient with exercise intolerance and myoglobinuria","volume":"45","author":"Andreu","year":"1999","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.ccm.2018.02.001_bib25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.nmd.2003.10.011","article-title":"A\u00a0novel sporadic mutation in cytochrome c oxidase subunit II as a cause of rhabdomyolysis","volume":"14","author":"McFarland","year":"2004","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.ccm.2018.02.001_bib26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mus.21649","article-title":"Exercise intolerance due to cytochrome b mutation","volume":"42","author":"Massie","year":"2010","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.ccm.2018.02.001_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1212\/WNL.40.1.103","article-title":"Recurrent respiratory insufficiency and depressed ventilatory drive complicating mitochondrial myopathies","volume":"40","author":"Barohn","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.ccm.2018.02.001_bib28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1600-0404.2007.00850.x","article-title":"Clinical evolution of Kearns-Sayre syndrome with polyendocrinopathy and respiratory failure","volume":"187","author":"Sanaker","year":"2007","journal-title":"Acta Neurol Scand Suppl"},{"issue":"11","key":"10.1016\/j.ccm.2018.02.001_bib29","first-page":"2020","article-title":"Nature and frequent of respiratory involvement in chronic progressive external ophthalmoplegia","volume":"258","author":"Smits","year":"2011","journal-title":"J\u00a0Neurol"},{"issue":"3","key":"10.1016\/j.ccm.2018.02.001_bib30","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ncl.2014.04.008","article-title":"A\u00a0pattern recognition approach to patients with a suspected myopathy","volume":"32","author":"Barohn","year":"2014","journal-title":"Neurol Clin"},{"issue":"1","key":"10.1016\/j.ccm.2018.02.001_bib31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/practneurol-2017-001708","article-title":"Metabolic myopathies: a practical approach","volume":"18","author":"Lilleker","year":"2018","journal-title":"Pract Neurol"},{"issue":"10","key":"10.1016\/j.ccm.2018.02.001_bib32","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1136\/jnnp.2005.078881","article-title":"Respiratory involvement in inherited primary muscle conditions","volume":"77","author":"Shahrizalia","year":"2006","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.ccm.2018.02.001_bib33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.nmd.2015.11.009","article-title":"Pulmonary function tests (maximum inspiratory pressure, maximum expiratory pressure, vital capacity, forced vital capacity) predict ventilator use in late-onset Pompe disease","volume":"26","author":"Johnson","year":"2016","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.ccm.2018.02.001_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00408-016-9959-z","article-title":"The maximal expiratory-to-inspiratory ratio and supine vital capacity as screening tests for diaphragm dysfunction","volume":"195","author":"Koo","year":"2017","journal-title":"Lung"},{"issue":"10","key":"10.1016\/j.ccm.2018.02.001_bib35","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMra1007236","article-title":"Dysfunction of the diaphragm","volume":"366","author":"McCool","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2018.02.001_bib36","series-title":"Principles of exercise testing and interpretation","author":"Wasserman","year":"2012"},{"issue":"2","key":"10.1016\/j.ccm.2018.02.001_bib37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1164\/rccm.167.2.211","article-title":"ATS\/ACCP statement on cardiopulmonary exercise testing","volume":"167","author":"American Thoracic Society; American College of Chest Physicians","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"Supplemental_1","key":"10.1016\/j.ccm.2018.02.001_bib38","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1513\/AnnalsATS.201701-014FR","article-title":"Cardiopulmonary exercise testing and metabolic myopathies","volume":"14","author":"Riley","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.ccm.2018.02.001_bib39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ymthe.2004.09.017","article-title":"Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers","volume":"11","author":"Raben","year":"2005","journal-title":"Mol Ther"},{"issue":"23","key":"10.1016\/j.ccm.2018.02.001_bib40","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1212\/WNL.0000000000004711","article-title":"Long-term benefit of enzyme replacement therapy in Pompe disease: a 5-year prospective study","volume":"89","author":"Kuperus","year":"2017","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ccm.2018.02.001_bib41","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/mt.2009.53","article-title":"The pharmacological chaperone N-butyldeoxynojirimycin enhances enzyme replacement therapy in Pompe disease fibroblasts","volume":"17","author":"Porto","year":"2009","journal-title":"Mol Ther"},{"issue":"6","key":"10.1016\/j.ccm.2018.02.001_bib42","doi-asserted-by":"crossref","first-page":"902","DOI":"10.2174\/138920111795542606","article-title":"Pompe disease: from new views on pathophysiology to innovative therapeutic strategies","volume":"12","author":"Parenti","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"issue":"8","key":"10.1016\/j.ccm.2018.02.001_bib43","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1212\/01.WNL.0000158682.85052.C0","article-title":"Respiratory failure in Pompe disease: treatment with noninvasive ventilation","volume":"64","author":"Mellies","year":"2005","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.ccm.2018.02.001_bib44","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.rmed.2013.03.004","article-title":"The role of respiratory management of Pompe disease","volume":"107","author":"Ambrosino","year":"2013","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.ccm.2018.02.001_bib45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.ccm.2018.02.001_bib46","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/mus.22329","article-title":"AANEM consensus committee on late-onset Pompe disease","volume":"45","author":"Cupler","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ccm.2018.02.001_bib47","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1164\/rccm.200307-885ST","article-title":"Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement","volume":"170","author":"Finder","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2018.02.001_bib48","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1183\/09031936.03.00048102","article-title":"Cough augmentation with mechanical insufflation\/exsufflation in patients with neuromuscular weakness","volume":"21","author":"Chatwin","year":"2003","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.ccm.2018.02.001_bib49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11940-017-0473-2","article-title":"Treatment opportunities in patients with metabolic myopathies","volume":"19","author":"\u00d8rngreen","year":"2017","journal-title":"Curr Treat Options Neurol"},{"issue":"26","key":"10.1016\/j.ccm.2018.02.001_bib50","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa031836","article-title":"The effect of oral sucrose on exercise tolerance in patients with McArdle\u2019s disease","volume":"349","author":"Vissing","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2018.02.001_bib51","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archneur.59.9.1395","article-title":"Spontaneous \u201csecond wind\u201d and glucose-induced second \u201csecond wind\u201d in McArdle disease: oxidative mechanisms","volume":"59","author":"Haller","year":"2002","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1016\/j.ccm.2018.02.001_bib52","first-page":"786","article-title":"Effect of oral sucrose shortly before exercise on work capacity in McArdle disease","volume":"65","author":"Anderson","year":"2008","journal-title":"Arch Neurol"},{"issue":"12","key":"10.1016\/j.ccm.2018.02.001_bib53","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/adc.2008.146548","article-title":"Carbohydrate- and protein-rich diets in McArdle disease: effects on exercise capacity","volume":"79","author":"Anderson","year":"2008","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.ccm.2018.02.001_bib54","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1001\/archneur.57.7.956","article-title":"Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial","volume":"57","author":"Vorgerd","year":"2000","journal-title":"Arch Neurol"},{"issue":"7","key":"10.1016\/j.ccm.2018.02.001_bib55","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1212\/WNL.59.7.1046","article-title":"Exercise intolerance in carnitine palmitoyltransferase II deficiency with IV and oral glucose","volume":"59","author":"\u00d8rngreen","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ccm.2018.02.001_bib56","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1212\/01.WNL.0000078195.05396.20","article-title":"Effect of diet\u00a0on exercise tolerance in carnitine palmitoyltransferase II deficiency","volume":"61","author":"\u00d8rngreen","year":"2003","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ccm.2018.02.001_bib57","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000177660","article-title":"Effects of oral ribose on muscle metabolism during bicycle ergometer in AMPD-deficient patients","volume":"35","author":"Wagner","year":"1991","journal-title":"Ann Nutr Metab"},{"issue":"4","key":"10.1016\/j.ccm.2018.02.001_bib58","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF01665856","article-title":"Ribose administration during exercise: effects on substrates and products of energy metabolism in healthy subjects and a patient with myoadenylate deaminase deficiency","volume":"69","author":"Gross","year":"1991","journal-title":"Klin Wochenschr"},{"issue":"Suppl 3","key":"10.1016\/j.ccm.2018.02.001_bib59","first-page":"iii24","article-title":"Long term ventilation in neurogenic respiratory failure","volume":"74","author":"Howard","year":"2003","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ccm.2018.02.001_bib60","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C","article-title":"A\u00a0randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies","volume":"20","author":"Tarnopolsky","year":"1997","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.ccm.2018.02.001_bib61","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1590\/1414-431x20143467","article-title":"Effect of L-carnitine on exercise performance in patients with mitochondrial myopathy","volume":"48","author":"Gimenes","year":"2015","journal-title":"Braz J Med Biol Res"},{"issue":"1\u20132","key":"10.1016\/j.ccm.2018.02.001_bib62","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0022-510X(90)90015-F","article-title":"Ubidecarenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial","volume":"100","author":"Bresolin","year":"1990","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.ccm.2018.02.001_bib63","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-6-34","article-title":"Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy","volume":"6","author":"G\u00fcng\u00f6r","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ccm.2018.02.001_bib64","series-title":"GeneReviews\u00ae","first-page":"1993","article-title":"Carnitine palmitoyltransferase II deficiency","author":"Wieser","year":"2004"},{"issue":"6","key":"10.1016\/j.ccm.2018.02.001_bib65","first-page":"385","article-title":"Myoadenylate deaminase deficiency: absence of correlation with exercise intolerance in 452 muscle biopsies","volume":"234","author":"Mercelis","year":"1987","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ccm.2018.02.001_bib66","series-title":"GeneReviews\u00ae","first-page":"1993","article-title":"Mitochondrial DNA deletion syndromes","author":"DiMauro","year":"2003"},{"key":"10.1016\/j.ccm.2018.02.001_bib67","first-page":"103","article-title":"Causes of death in adults with mitochondrial disease","volume":"26","author":"Barends","year":"2016","journal-title":"JIMD Rep"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027252311830025X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027252311830025X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:56:23Z","timestamp":1759452983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027252311830025X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S027252311830025X"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2018.02.001","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic Myopathies and the Respiratory System","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2018.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}